Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

NCT06252428 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2024-03-05

No results posted yet for this study

Summary

This descriptive cross-sectional study will beconducted in Suez Canal University Hospitals (SCUHs) in Ismailia, Egypt. The study aims to detect Escherichia coli biofilm producers to improve prognosis and treatment and reduce morbidity and mortality rates due to this infection.

Conditions

  • Escherichia Coli Infections

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Rania Kishk, professor · Faculty of Medicine - Suez Canal University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2024-02-01
Completion
2024-02-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06252428 on ClinicalTrials.gov